Prostate-specific antigen best practice policy - part II: Prostate cancer staging and post-treatment follow-up

被引：31
作者：
Carroll, P
Coley, C
McLeod, D
Schellhammer, P
Sweat, G
Wasson, J
Zietman, A
Thompson, I
机构：
[1] Univ Texas, Hlth Sci Ctr, Div Urol, San Antonio, TX 78284 USA
[2] Univ Calif San Francisco, Med Ctr, Dept Urol, San Francisco, CA 94143 USA
[3] Harvard Univ, Hlth Serv, Dept Med, Cambridge, MA 02138 USA
[4] Walter Reed Army Med Ctr, Dept Urol, Washington, DC 20307 USA
[5] Eastern Virginia Grad Sch Med, Norfolk, VA USA
[6] Mayo Clin, Dept Family Med, Rochester, MN USA
[7] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Community & Family Med, Hanover, NH 03756 USA
[8] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiat Oncol, Boston, MA USA
来源：
UROLOGY | 2001年 / 57卷 / 02期
关键词：
D O I：
10.1016/S0090-4295(00)00994-8
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：225 / 229
页数：5
相关论文
共 39 条
[1]   RADIOIMMUNOSCINTIGRAPHY OF PELVIC LYMPH-NODES WITH (111)INDIUM-LABELED MONOCLONAL-ANTIBODY CYT-356 [J].
BABAIAN, RJ ;
SAYER, J ;
PODOLOFF, DA ;
STEELHAMMER, LC ;
BHADKAMKAR, VA ;
GULFO, JV .
JOURNAL OF UROLOGY, 1994, 152 (06) :1952-1955
[2]   PELVIC LYMPHADENECTOMY CAN BE OMITTED IN SELECTED PATIENTS WITH CARCINOMA OF THE PROSTATE - DEVELOPMENT OF A SYSTEM OF PATIENT SELECTION [J].
BISHOFF, JT ;
REYES, A ;
THOMPSON, IM ;
HARRIS, MJ ;
STCLAIR, SR ;
GOMELLA, L ;
BUTZIN, CA .
UROLOGY, 1995, 45 (02) :270-274
[3]   ELIMINATING THE NEED FOR BILATERAL PELVIC LYMPHADENECTOMY IN SELECT PATIENTS WITH PROSTATE-CANCER [J].
BLUESTEIN, DL ;
BOSTWICK, DG ;
BERGSTRALH, EJ ;
OESTERLING, JE .
JOURNAL OF UROLOGY, 1994, 151 (05) :1315-1320
[4]   Influence of local tumour stage and grade on reliability of serum prostate-specific antigen in predicting skeletal metastases in patients with adenocarcinoma of the prostate [J].
Bruwer, G ;
Heyns, CF ;
Allen, FJ .
EUROPEAN UROLOGY, 1999, 35 (03) :223-227
[5]   Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy [J].
Cher, ML ;
Bianco, FJ ;
Lam, JS ;
Davis, LP ;
Grignon, DJ ;
Sakr, WA ;
Banerjee, M ;
Pontes, JE ;
Wood, DP .
JOURNAL OF UROLOGY, 1998, 160 (04) :1387-1391
[6]   Prostate-specific antigen after cryosurgical ablation of the prostate - Defining the appropriate response [J].
Connolly, JA ;
Shinohara, K ;
Presti, JC ;
Carroll, PR .
UROLOGIC CLINICS OF NORTH AMERICA, 1997, 24 (02) :415-+
[7]  
Cox JD, 1997, INT J RADIAT ONCOL, V37, P1035
[8]   The PSA nadir that indicates potential cure after radiotherapy for prostate cancer - Editorial comment [J].
Klein, EA ;
Kupelian, PJ .
UROLOGY, 1997, 49 (03) :326-326
[9]  
D'Amico A V, 1996, Cancer J Sci Am, V2, P343
[10]   The proportional decrease in prostate specific antigen level best predicts the duration of survival after hormonal therapy in patients with metastatic carcinoma of the prostate [J].
Evans, CP ;
Gajendran, V ;
Tewari, A ;
Aslam, K ;
Juster, R ;
Gange, S ;
Eason, A ;
Narayan, P .
BRITISH JOURNAL OF UROLOGY, 1996, 78 (03) :426-431
1234